Literature DB >> 9230751

Impairment of neural nitric oxide-mediated relaxation after antigen exposure in guinea pig airways in vitro.

M Miura1, H Yamauchi, M Ichinose, Y Ohuchi, N Kageyama, M Tomaki, N Endoh, K Shirato.   

Abstract

Nitric oxide (NO), a neurotransmitter of inhibitory nonadrenergic noncholinergic (iNANC) nerves in airways, is a radical with a short half-life, and its function may be modified by airway inflammation. To test this hypothesis, we examined whether airway allergic inflammation affects iNANC responses mediated by NO in guinea pigs in vitro. Animals sensitized with ovalbumin (OA) were challenged with 0.03% OA (OA group) or saline (saline group) by inhalation on 3 consecutive days. On the day after the final challenge, iNANC responses elicited by electrical field stimulation (2 to 16 Hz) or relaxation responses to 3-morpholinosydnonimine (SIN-1), 10(-8) to 10(-4) M, were obtained in the tracheal strips precontracted by histamine (3 x 10(-6) M) in the presence of atropine and propranolol (both 10(-6) M). The INANC responses of the OA group were significantly attenuated compared with those of the saline group (p < 0.05), and the inhibitory effect of a NO synthase (NOS) inhibitor, Nm-nitro-L-arginine methyl ester, on the INANC responses was abolished in the OA group. SIN-1-induced tracheal smooth muscle relaxation was also significantly affected by antigen exposure (p < 0.05), the effect of which disappeared in the presence of a NO scavenger, carboxy PTIO (3 x 10(-6) M). The impairment of the INANC responses after antigen exposure was significantly restored by superoxide dismutase (1,000 U/ml), especially at lower frequencies. Histochemical demonstration of NADPH-diaphorase-positive nerves representing neural NOS density was not different between the two groups. These results suggest that allergic airway inflammation impairs neural NO-induced relaxation, presumably by inhibiting the access of neural NO to the airway smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230751     DOI: 10.1164/ajrccm.156.1.9606040

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Effects of nitrogen dioxide exposure and ascorbic acid supplementation on exhaled nitric oxide in healthy human subjects.

Authors:  D C Chambers; J G Ayres
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

2.  Genetic polymorphisms in arginase I and II and childhood asthma and atopy.

Authors:  Huiling Li; Isabelle Romieu; Juan-Jose Sienra-Monge; Matiana Ramirez-Aguilar; Blanca Estela Del Rio-Navarro; Emily O Kistner; Håkon K Gjessing; Irma Del Carmen Lara-Sanchez; Grace Y Chiu; Stephanie J London
Journal:  J Allergy Clin Immunol       Date:  2005-11-28       Impact factor: 10.793

3.  Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness.

Authors:  Herman Meurs; Sue McKay; Harm Maarsingh; Marco A M Hamer; Lejla Macic; Niek Molendijk; Johan Zaagsma
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 4.  Multiple roles of nitric oxide in the airways.

Authors:  F L M Ricciardolo
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

Review 5.  Mini review: Neural mechanisms underlying airway hyperresponsiveness.

Authors:  Alexandra B Pincus; Allison D Fryer; David B Jacoby
Journal:  Neurosci Lett       Date:  2021-03-02       Impact factor: 3.046

6.  Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma.

Authors:  Harm Maarsingh; John Leusink; I Sophie T Bos; Johan Zaagsma; Herman Meurs
Journal:  Respir Res       Date:  2006-01-12

7.  Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation.

Authors:  Harm Maarsingh; Marieke A Tio; Johan Zaagsma; Herman Meurs
Journal:  Respir Res       Date:  2005-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.